COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,974 Articles (22,604 medRxiv, 8,370 bioRxiv)

Most recent first Previous |  Page 620: Articles 6191-6200  | Next

Antibiotic Resistance associated with the COVID-19 Pandemic: A Rapid Systematic Review
Langford, B. J., Soucy, J.-P. R., Leung, V., So, M., Kwan, A. T., Portnoff, J. S., Bertagnolio, S., Raybardhan, S., MacFadden, D., Daneman, N.
10.1101/2022.09.01.22279488 — Posted: 2022-09-02
Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity
Kim, D., Biancon, G., Bai, Z., VanOudenhove, J., Liu, Y., Kothari, S., Gowda, L., Kwan, J. M., Buitrago-Pocasangre, N. C., Lele, N., Asashima, H., Racke, M. K., Wilson, J. E., Givens, T. S., Tomayko, M. M., Schulz, W. L., Longbrake, E. E., Hafler, D. A., Halene, S., Fan, R.
10.1101/2022.08.31.506117 — Posted: 2022-09-02
Structural basis of nirmatrelvir and ensitrelvir resistance profiles against SARS-CoV-2 Main Protease naturally occurring polymorphisms
Noske, G. D., Silva, E. S., Godoy, M. O., Dolci, I., Fernandes, R. S., Guido, R. V. C., Sjo, P., Oliva, G., Godoy, A. S.
10.1101/2022.08.31.506107 — Posted: 2022-09-01
Impact of COVID-19 and Effects of Vaccination with BNT162b2 on Patient-Reported Health-Related Quality of Life, Symptoms, and Work Productivity Among US Adult Outpatients with SARS-CoV-2
Di Fusco, M., Sun, X., Moran, M. M., Coetzer, H., Zamparo, J. M., Puzniak, L., Alvarez, M. B., Tabak, Y. P., Cappelleri, J. C.
10.1101/2022.08.31.22279264 — Posted: 2022-09-01
COVID-19 individual participant data meta-analyses. Can there be too many? Results from a rapid systematic review
Maxwell, L., Shreedhar, P., Levis, B., Chavan, S. A., Akter, S., Carabali, M.
10.1101/2022.09.01.22279485 — Posted: 2022-09-01
Risk averse reproduction numbers improve resurgence detection
Parag, K. V., Obolski, U.
10.1101/2022.08.31.22279450 — Posted: 2022-09-01
Implementation of a Non-Invasive Helmet Ventilation Solution for the Management of Severe COVID-19 Respiratory Disease in Nigeria: The CircumVent Project
Ahonkhai, A. A., Abdu, A., Adekanmbi, O., Ajayi, N. A., Ajayi, S., Akpobi, H., Akpochafo, E. B., Aliyu, M. H., Ayuk, A. C., Dada, A. A., Ezechi, O. C., Falade, C. O., Horstein, A., Olusola, I., Idigbe, I., Mogaj, S., Morenikeji, A. A., Musa, B. M., Nwosu, N. I., Odewabi, A. A., Ofokotun, I., Ogedegbe, G., Ogueh, O., Oyewole, T. O., Sotannde, A. I., Steinbach, A. B., Ulasi, I. I., Ukwaj, K. N., Unigwe, U. S., Usman, O. A., Uzoke, C., Musa, A. Z., Rotimi, M. K., Akase, I. E., Adeyemo, W. L., Fenton, A. A., Salako, B. L.
10.1101/2022.08.30.22279372 — Posted: 2022-09-01
A Novel Dry-Stabilized Whole Blood Microsampling and Protein Extraction Method for Testing of SARS-CoV-2 Antibody Titers
McCarthy, P. T., Pathakamuri, J. A., Kuebler, D., Neves, J., Krohn, M., Rohall, M., Archibeque, I., Giese, H., Werner, M., Thomann, U.
10.1101/2022.08.31.22279395 — Posted: 2022-09-01
Effects of inbound attendees of a mass gathering event on the COVID-19 epidemic using individual-based simulations
SAITO, M., Katayama, K., Naruse, A., Ruan, P., Murakami, M., Okuda, T., Ysutaka, T., Naito, W., Tsubokura, M., Imoto, S.
10.1101/2022.08.31.22279428 — Posted: 2022-09-01
Effectiveness of the COVID-19 vaccines against severe disease with Omicron sub-lineages BA.4 and BA.5 in England
Kirsebom, F., Andrews, N., Stowe, J., Ramsay, M., Lopez Bernal, J.
10.1101/2022.08.31.22279444 — Posted: 2022-09-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).